|Bid||32.77 x 100|
|Ask||32.78 x 1900|
|Day's Range||32.65 - 33.08|
|52 Week Range||27.60 - 56.44|
|PE Ratio (TTM)||420.24|
|Dividend & Yield||1.36 (4.17%)|
|1y Target Est||36.83|
Xenon Pharmaceuticals Inc. and Teva Pharmaceutical Industries Ltd. said premarket Tuesday that their mid-stage nerve pain drug missed its primary endpoint and secondary endpoints. Xenon shares plummeted ...
The June 15 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks shrank.
JERUSALEM and BURNABY, British Columbia, June 27, 2017-- Teva Pharmaceutical Industries Ltd. and Xenon Pharmaceuticals Inc. announce top-line results in a Phase II study of topical TV-45070 in patients ...